MCTA — Charming Medical Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Charming Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	20-F
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Revenue
Total Revenue	3.53	6.02	6.22	4.81
Cost of Revenue
Gross Profit	3.51	6	6.21	4.77
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	4.05	5.01	4.83	4.82
Operating Profit	-0.521	1.01	1.39	-0.017
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.42	1	1.44	0.133
Provision for Income Taxes
Net Income After Taxes	-0.336	0.822	1.2	-0.023
Minority Interest
Net Income Before Extraordinary Items
Net Income	-0.305	0.778	1.2	-0.023
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.305	0.778	1.2	-0.023
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.018	0.046	0.071	-0.002